The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,076.00
Bid: 1,070.00
Ask: 1,076.00
Change: 14.00 (1.32%)
Spread: 6.00 (0.561%)
Open: 1,056.00
High: 1,076.00
Low: 1,032.00
Prev. Close: 1,062.00
CVSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

SAYE Option Scheme & PDMR Dealing

25 Nov 2022 16:22

RNS Number : 6817H
CVS Group plc
25 November 2022
 

 

 

25 November 2022

CVS Group plc

("CVS" or the "Company")

 

Grant of Options under CVS Group plc SAYE Option Scheme & PDMR Dealing

CVS Group plc (the "Company") announces that as part of its 2022/2023 Save As You Earn share scheme (the "SAYE Scheme"), which is open to all employees of the Group, the Executive Directors named below have elected to participate in the SAYE Scheme and have been granted SAYE Scheme options as follows:

 

Richard Fairman 380 SAYE scheme options

Robin Alfonso 403 SAYE scheme options

Ben Jacklin 403 SAYE scheme options

 

Eligible employees were invited to subscribe for options over the Company's ordinary shares of 0.2 pence each ("Ordinary Shares") with an exercise price of 1,515 pence per share, representing a 20% discount to the average closing middle market price for the three dealing days prior to 1 November 2022, being the invitation date.

 

In response to accepted invitations, a total of 381,689 SAYE Scheme options over Ordinary Shares were granted on 25 November 2022, equating to 0.54% of the current issued ordinary share capital. Subject to the rules of the SAYE Scheme, these options will be capable of exercise from the maturity date on 1 January 2026.

 

The notification below, made in accordance with the requirements of UK MAR, provides further detail.

 

Contacts:

 

CVS Group plc via Camarco

Richard Fairman, CEO

Jenny Farrer, Group Company Secretary

 

Peel Hunt LLP (Nominated Adviser & Broker) +44 (0)20 7418 8900

Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose

 

Berenberg (Joint Broker) +44 (0)20 3207 7800

Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser

 

Camarco (Financial PR)

Geoffrey Pelham-Lane +44 (0)7733 124 226

Ginny Pulbrook +44 (0)7961 315 138

 Toby Strong +44 (0)7789 151 644 

 

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Richard Fairman

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

CVS Group plc

b)

LEI

213800J41XDQ2NX48O05

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Options over Ordinary shares of 0.2 pence each

 

 

GB00B2863827

b)

Nature of the transaction

Grant of Options under the SAYE Scheme.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Exercise price of 1,515p

380

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price

e)

Date of the transaction

25 November 2022

f)

Place of the transaction

Off market

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Robin Alfonso

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

CVS Group plc

b)

LEI

213800J41XDQ2NX48O05

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Options over Ordinary shares of 0.2 pence each

 

 

GB00B2863827

b)

Nature of the transaction

Grant of Options under the SAYE Scheme.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Exercise price of 1,515p

403

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price

e)

Date of the transaction

25 November 2022

f)

Place of the transaction

Off market

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Ben Jacklin

2

Reason for the notification

a)

Position/status

Chief Operating Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

CVS Group plc

b)

LEI

213800J41XDQ2NX48O05

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Options over Ordinary shares of 0.2 pence each

 

 

GB00B2863827

b)

Nature of the transaction

Grant of Options under the SAYE Scheme.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Exercise price of 1,515p

 

403

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price

e)

Date of the transaction

25 November 2022

f)

Place of the transaction

Off market

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHPPGBGGUPPGQA
Date   Source Headline
23rd Jul 20138:09 amRNSTrading Update
10th Jul 20131:24 pmRNSHolding(s) in Company
4th Jul 201310:25 amRNSHolding(s) in Company
12th Jun 20131:08 pmRNSHolding(s) in Company
31st May 20137:00 amRNSTotal Voting Rights
28th May 20137:00 amRNSBlocklisting Interim Review
23rd May 201312:33 pmRNSHolding(s) in Company
30th Apr 20132:25 pmRNSHolding(s) in Company
30th Apr 201311:55 amRNSHolding(s) in Company
30th Apr 20137:00 amRNSTotal Voting Rights
2nd Apr 20137:00 amRNSDirectorate Change
28th Mar 20137:00 amRNSTotal Voting Rights
21st Mar 20139:26 amRNSHolding(s) in Company
19th Mar 20135:12 pmRNSDirector Dealing
14th Mar 201312:05 pmRNSDirector Dealing
13th Mar 20137:00 amRNSInterim Results
8th Feb 201312:01 pmRNSHolding(s) in Company
31st Jan 20137:00 amRNSTotal Voting Rights
25th Jan 201312:15 pmRNSHolding(s) in Company
23rd Jan 20134:57 pmRNSHolding(s) in Company
23rd Jan 201312:41 pmRNSHolding(s) in Company
23rd Jan 201312:38 pmRNSHolding(s) in Company
21st Jan 20135:01 pmRNSHolding(s) in Company
10th Jan 20132:02 pmRNSDirector Dealing
7th Jan 20134:07 pmRNSDirectors' Dealings
14th Dec 20123:04 pmRNSExercise of Share Options
14th Dec 201211:34 amRNSResult of AGM
14th Dec 20127:00 amRNSAnnual General Meeting Statement
22nd Nov 201212:28 pmRNSBlock Admission Application
20th Nov 201212:05 pmRNSAnnual Report and Notice of AGM
15th Nov 20127:00 amRNSDirectorate Change
31st Oct 20123:29 pmRNSHolding(s) in Company
29th Oct 20127:00 amRNSChange of Name of Nominated Adviser and Broker
26th Oct 20128:00 amRNSHolding(s) in Company
19th Oct 20121:03 pmRNSHolding(s) in Company
19th Oct 201212:41 pmRNSHolding(s) in Company
11th Oct 20129:32 amRNSHolding(s) in Company
3rd Oct 201210:49 amRNSHolding(s) in Company
28th Sep 20124:55 pmRNSLTIP Award
28th Sep 20124:52 pmRNSAnnual Report
25th Sep 20127:00 amRNSPreliminary Results - the year ended 30 June 2012
24th Sep 20126:28 pmRNSHolding(s) in Company
18th Sep 201212:01 pmRNSHolding(s) in Company
18th Sep 20129:59 amRNSHolding(s) in Company
17th Jul 20123:50 pmRNSHolding(s) in Company
11th Jul 20127:00 amRNSTrading Update and Future Director Change
26th Apr 201212:30 pmRNSHolding(s) in Company
25th Apr 20123:44 pmRNSHolding(s) in Company
20th Apr 20124:27 pmRNSDirector/PDMR Shareholding
11th Apr 20125:07 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.